Posts Tagged ‘Consumer Price Index’

200 Economists Come Out in Favor of ObamaCare

Monday, April 25th, 2011

Approximately 200 healthcare economists are urging Congress to reject a premium support model for Medicare and instead “support vigorous implementation” of last year’s health reform law.  The economists – who are primarily academics – sent a letter to Congressional leadership saying there are two general strategies to Medicare spending and the “right” approach can be found in the Patient Protection and Affordable Care Act (ACA). “It supports research on identifying those procedures that work best,” according to the letter.  “It emphasizes payment reforms and new ways of organizing delivery of care to slow spending growth while improving care,” it said, adding that the Congressional Budget Office (CBO) projects that the Affordable Care Act will decelerate annual growth of per-person Medicare spending over the next 10 years below the rate of overall economic growth.

House Republicans recently released their fiscal year 2012 budget, which seeks to convert Medicare to a premium-support system.  Patients would be given a list of health plans from which to choose, and Medicare would subsidize the premiums.  In their letter to congressional leaders, the healthcare economists said the term “premium support” mislabels a voucher program, which they say will end up forcing consumers to pay more.  Citing CBO statistics, the economists expressed concern that current proposals link voucher payments to growth in the Consumer Price Index adjusted for population growth.  “Because medical care costs are rising much more rapidly than the CPI, this guarantees that the value of the proposed Medicare vouchers would erode over time,” according to the CBO.

Some believe that forcing people to pay more out-of-pocket expenses will make them better healthcare consumers.  Writing in The New Republic, Jonathan Cohn says that “The solution, as this argument goes, is to redesign insurance so that it forces people to pay more out-of-pocket expenses.  And, within reason, it’s not a bad idea.  Most economists, even those on the left, would agree that excessive coverage leads to higher health care spending.  But redesigning insurance in a way that actually lowers spending and, by the way, promotes good health, is a lot more complicated than merely giving people “more skin in the game,” as conservatives like to put it.  A new study by researchers affiliated with the Rand Corporation suggests why.

“The study, published in the American Journal of Managed Care, compares trends in medical spending by two groups of people — one group with traditional insurance and one with newly purchased high-deductible coverage,” Cohn notes.  “It appears to be the largest study of its kind, and the three authors did their best to adjust for factors like age, occupation and underlying medical conditions.  The result? People with high-deductible plans spent substantially less on their medical care.  That’s good news.  Or is it?  Giving people more skin in the game has distributional consequences.  It shifts the burden of medical expenses onto those people with the most serious medical problems, which is, arguably, what insurance is designed to prevent.  In addition, discriminating medical consumers are not always intelligent medical consumers.  People may decide to skimp on useful medical care rather than the superfluous kind.”

According to White House press secretary Jay Carney, healthcare savings are necessary to control the deficit. Carney said that the president would build on the work of his debt commission, whose recommendations he initially refrained from endorsing.  Carney also praised a small group of senators from both parties, known as the “Gang of Six”, which is establishing a framework where a sharply divided Congress can compromise on deficits.  “The president understands very well that healthcare spending is a major driver of our deficit and debt problem,” Carney said.  “He believes we can achieve those savings in ways that protect the people that these programs are supposed to, and were designed to, support and help.”

AARP Slams Rising Brand-Name Drug Prices

Monday, September 13th, 2010

AARP says brand-name drugs prescribed to senior citizens rose 8.3 percent in 2009, despite the recession.  The 217 most commonly used brand-name drugs prescribed to senior citizens rose in price by 8.3 percent in 2009, according to a new study by AARP. What is especially startling about this number is that the largest increase in years occurred in a deflationary time.  Retail prices for the most popular brand-name drugs have risen 41.5 percent over the last five years.  Contrast that with the Consumer Price Index, which increased just 13.3 percent during the same timeframe.

Pharmaceutical manufacturers are disputing the numbers, claiming that select brand-name prices did not account for the fact that more people are using lower-priced generic drugs.  Generics make up approximately 75 percent of all prescriptions filled in the United States, according to research firm IMS Health.  The pharmaceutical industry cited a government survey that showed drug prices rose by just 3.4 percent during 2009.  According to Jonathan Church, an economist with the Bureau of Labor Statistics, his study included generic and brand-name drug prices.

John A. Vernon, an assistant professor of health policy at the University of North Carolina, Chapel Hill, lauded AARP for adapting its methodology to count retail prices instead of wholesale.  Still, he noted, the study is flawed.  “It can be shown that branded prices are higher here than they are in other countries, but we have the lowest and the most competitively priced generic drugs in the world, and the generic share is going up rapidly,” he said.  “Just focusing on brands I think is unfair.”

John C. Rother, AARP’s senior vice president for policy and strategy, is in agreement that generic drug prices have been stable or even fallen.  He added that the new retail price analysis demonstrates why many older Americans still struggle to pay for brand-name drugs they need to manage chronic medical conditions.  “Brand-name retail prices have been accelerating year-to-year even when inflation has been nonexistent in the rest of the economy,” he said.

Overall Physician Compensation Levels Fell in 2009

Thursday, August 26th, 2010

The bad economy cuts into 2009 physicians’ paychecks.  Doctors’ salaries fell slightly in 2009, according to the 17th annual Physician Compensation Survey compiled by Modern Healthcare magazine.

The most recent survey tracked 23 specialties and determined that only five had average pay increases higher than the 2.7 percent inflation rate calculated by the Consumer Price Index.  These were dermatology, which rose 5.3 percent; pediatrics, which rose 4.5 percent; neurology and pathology, which rose 3.3 percent; and hospital medicine, which rose 2.8 percent.  Orthopedic surgeons topped out the compensation list with their average pay climbing 1.9 percent to $485,297.

Eight specialties saw slight decreases.  Plastic surgery was down 3.3 percent to $376,849; gastroenterology was down 2.8 percent to $409,628; intensive medicine was down 1.7 percent to $257,797; radiation oncology was down 1.7 percent to $420,661; urology was down 1.4 percent to $391,406; emergency medicine was down 1.1 percent to $266,826; invasive cardiology was down 0.9 percent to $450,016; and noninvasive cardiology was down 0.9 percent to $393,181.

According to William Jessee, M.D., president and CEO of the Medical Group Management Association, “Clearly, there had to be some impact from the economy.  Actually, I was pleased the numbers were as good as they were given the recession.  Certainly, it showed a comeback in the second half of 2009.”  A pediatrician, Jessee, added that primary-care physicians saw their pay rise by 2.8 percent last year, which he views as part of an effort to attract more medical school graduates to that specialty.  He warns against over-reacting to the data.  “Keep in mind the increase is not anything to write home about – 2.8 percent is not a windfall,” Jessee said.